|
US7258857B2
(en)
*
|
1996-11-22 |
2007-08-21 |
The Trustees Of Columbia University In The City Of New York |
Rage-related methods for treating inflammation
|
|
US6790443B2
(en)
*
|
1996-11-22 |
2004-09-14 |
The Trustees Of Columbia University In The City Of New York |
Method for treating symptoms of diabetes
|
|
US7101838B2
(en)
|
1997-08-05 |
2006-09-05 |
The Trustees Of Columbia University In The City Of New York |
Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts
|
|
US6465422B1
(en)
*
|
1998-04-17 |
2002-10-15 |
The Trustees Of Columbia University In The City Of New York |
Method for inhibiting tumor invasion or spreading in a subject
|
|
AU765719B2
(en)
*
|
1998-10-06 |
2003-09-25 |
Trustees Of Columbia University In The City Of New York, The |
Extracellular novel rage binding protein (EN-RAGE) and uses thereof
|
|
PE20020394A1
(es)
|
2000-08-18 |
2002-06-21 |
Agouron Pharma |
Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
|
|
AU2002213192A1
(en)
*
|
2000-10-13 |
2002-04-22 |
The Trustees Of Columbia University In The City Of New York |
A method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
|
|
CN1235583C
(zh)
|
2001-03-05 |
2006-01-11 |
特兰斯泰克制药公司 |
用作治疗剂的苯并咪唑衍生物
|
|
CA2440042C
(en)
|
2001-03-05 |
2011-09-27 |
Transtech Pharma, Inc. |
Carboxamide derivatives as therapeutic agents
|
|
US6815175B2
(en)
|
2001-03-16 |
2004-11-09 |
Cornell Research Foundation, Inc. |
Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder
|
|
EP1380290A1
(en)
*
|
2002-07-09 |
2004-01-14 |
Universitair Medisch Centrum Utrecht |
Cross-beta structure pathway and its therapeutic relevance
|
|
MXPA05001758A
(es)
*
|
2002-08-16 |
2005-08-19 |
Wyeth Corp |
Composiciones y metodos para el tratamiento de trastornos asociados a receptor para productos finales de glicatacion avanzada (rage).
|
|
US7732162B2
(en)
|
2003-05-05 |
2010-06-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
|
|
US8067371B2
(en)
|
2003-05-09 |
2011-11-29 |
The Trustees Of Columbia University In The City Of New York |
RAGE G82S-related methods and compositions for treating inflammatory disorders
|
|
WO2006012415A2
(en)
|
2004-07-20 |
2006-02-02 |
Critical Therapeutics, Inc. |
Rage protein derivatives
|
|
ES2473587T3
(es)
|
2004-08-03 |
2014-07-07 |
Transtech Pharma, Inc. |
Proteínas de fusión de RAGE y métodos de uso
|
|
EP1776459A1
(en)
*
|
2004-08-03 |
2007-04-25 |
Transtech Pharma, Inc. |
Rage fusion proteins and methods of use
|
|
EP1869464A4
(en)
*
|
2005-03-17 |
2009-12-02 |
Univ Columbia |
RAGE-DIAPHANOUS INTERACTION AND CORRESPONDING COMPOSITIONS AND METHODS
|
|
EP2386861A3
(en)
|
2005-07-13 |
2012-07-18 |
Crossbeta Biosciences B.V. |
Cross-ß structure binding compounds
|
|
US8114832B2
(en)
|
2005-07-13 |
2012-02-14 |
Crossbeta Biosciences B.V. |
Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
|
|
EP1963786B1
(en)
*
|
2005-12-23 |
2013-07-24 |
GCoder Systems AB |
Positioning pattern
|
|
WO2007094926A2
(en)
*
|
2006-02-09 |
2007-08-23 |
Transtech Pharma, Inc. |
Rage fusion proteins and methods of use
|
|
MX2008011933A
(es)
*
|
2006-03-21 |
2008-12-18 |
Wyeth Corp |
Metodos y composiciones para antagonismo de rage.
|
|
EA017291B1
(ru)
|
2006-05-05 |
2012-11-30 |
Транстек Фарма, Инк. |
Белки слияния на основе rage, их композиции и способы их применения
|
|
WO2008100470A2
(en)
*
|
2007-02-15 |
2008-08-21 |
Transtech Pharma, Inc. |
Rage - immunoglobulin fusion proteins
|
|
JP5930573B2
(ja)
|
2007-03-01 |
2016-06-15 |
プロビオドルグ エージー |
グルタミニルシクラーゼ阻害剤の新規使用
|
|
WO2008128985A1
(en)
|
2007-04-18 |
2008-10-30 |
Probiodrug Ag |
Thiourea derivatives as glutaminyl cyclase inhibitors
|
|
US20100254983A1
(en)
*
|
2007-06-07 |
2010-10-07 |
Ann Marie Schmidt |
Uses of rage antagonists for treating obesity and related diseases
|
|
US8398977B2
(en)
|
2007-06-14 |
2013-03-19 |
Galactica Pharmaceuticals, Inc. |
Rage fusion proteins
|
|
CN102089430B
(zh)
*
|
2008-05-09 |
2015-02-04 |
Abbvie公司 |
针对渐进性糖化终极产物受体(rage)的抗体及其用途
|
|
CN102037119B
(zh)
|
2008-05-23 |
2015-06-24 |
Siwa有限公司 |
促进再生的方法、组合物及设备
|
|
US9034341B2
(en)
|
2009-04-20 |
2015-05-19 |
Transtech Pharma, Llc |
Control of RAGE fusion protein glycosylation and RAGE fusion protein compositions
|
|
PL2475428T3
(pl)
|
2009-09-11 |
2015-12-31 |
Probiodrug Ag |
Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej
|
|
CA2772797C
(en)
|
2009-09-30 |
2018-09-25 |
Transtech Pharma, Inc. |
Substituted imidazole derivatives
|
|
TWI510241B
(zh)
|
2010-02-18 |
2015-12-01 |
Vtv Therapeutice Llc |
苯基-雜芳基衍生物及其使用方法
|
|
ES2586231T3
(es)
|
2010-03-03 |
2016-10-13 |
Probiodrug Ag |
Inhibidores de glutaminil ciclasa
|
|
MX2012010470A
(es)
|
2010-03-10 |
2012-10-09 |
Probiodrug Ag |
Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5).
|
|
US8541596B2
(en)
|
2010-04-21 |
2013-09-24 |
Probiodrug Ag |
Inhibitors
|
|
WO2012047629A2
(en)
|
2010-09-27 |
2012-04-12 |
Siwa Corporation |
Selective removal of age-modified cells for treatment of ather0sclerosis
|
|
US8721571B2
(en)
|
2010-11-22 |
2014-05-13 |
Siwa Corporation |
Selective removal of cells having accumulated agents
|
|
EP2686313B1
(en)
|
2011-03-16 |
2016-02-03 |
Probiodrug AG |
Benzimidazole derivatives as inhibitors of glutaminyl cyclase
|
|
US9309728B2
(en)
*
|
2012-05-14 |
2016-04-12 |
Nabors Drilling International Limited |
Drilling rig employing tubular handling device
|
|
KR20150064743A
(ko)
|
2012-10-05 |
2015-06-11 |
트랜스테크 파르마 엘엘씨 |
경도 및 중등도 알츠하이머 병의 치료
|
|
CN105143859B
(zh)
*
|
2013-03-14 |
2018-12-04 |
惠普发展公司,有限责任合伙企业 |
检测物质的设备和制造这样的设备的方法
|
|
CA2925757A1
(en)
*
|
2013-09-30 |
2015-04-02 |
Cornell University |
Cardiolipin-targeted peptides inhibit beta-amyloid oligomer toxicity
|
|
AU2015318036B2
(en)
|
2014-09-19 |
2021-07-01 |
Siwa Corporation |
Anti-AGE antibodies for treating inflammation and auto-immune disorders
|
|
US9993535B2
(en)
|
2014-12-18 |
2018-06-12 |
Siwa Corporation |
Method and composition for treating sarcopenia
|
|
US10358502B2
(en)
|
2014-12-18 |
2019-07-23 |
Siwa Corporation |
Product and method for treating sarcopenia
|
|
IL283726B2
(en)
|
2016-02-19 |
2025-05-01 |
Siwa Corp |
A preparation containing an antibody to advanced glycation end products (AGE) for use in the treatment of breast cancer
|
|
EP3443007A1
(en)
|
2016-04-15 |
2019-02-20 |
Siwa Corporation |
Anti-age antibodies for treating neurodegenerative disorders
|
|
US11213585B2
(en)
|
2016-06-23 |
2022-01-04 |
Siwa Corporation |
Vaccines for use in treating various diseases and disorders
|
|
US10995151B1
(en)
|
2017-01-06 |
2021-05-04 |
Siwa Corporation |
Methods and compositions for treating disease-related cachexia
|
|
US10961321B1
(en)
|
2017-01-06 |
2021-03-30 |
Siwa Corporation |
Methods and compositions for treating pain associated with inflammation
|
|
US10925937B1
(en)
|
2017-01-06 |
2021-02-23 |
Siwa Corporation |
Vaccines for use in treating juvenile disorders associated with inflammation
|
|
US10858449B1
(en)
|
2017-01-06 |
2020-12-08 |
Siwa Corporation |
Methods and compositions for treating osteoarthritis
|
|
BR112019021471A2
(pt)
|
2017-04-13 |
2020-05-12 |
Siwa Corporation |
Anticorpo monoclonal humanizado de produto final da glicação avançada
|
|
PL3461819T3
(pl)
|
2017-09-29 |
2020-11-30 |
Probiodrug Ag |
Inhibitory cyklazy glutaminylowej
|
|
US11518801B1
(en)
|
2017-12-22 |
2022-12-06 |
Siwa Corporation |
Methods and compositions for treating diabetes and diabetic complications
|
|
WO2019190822A1
(en)
|
2018-03-28 |
2019-10-03 |
Vtv Therapeutics Llc |
Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
|
|
WO2019190823A1
(en)
|
2018-03-28 |
2019-10-03 |
Vtv Therapeutics Llc |
Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chlorophenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
|
|
JP7464591B2
(ja)
|
2018-10-10 |
2024-04-09 |
ブイティーブイ・セラピューティクス・エルエルシー |
[3-(4-{2-ブチル-1-[4-(4-クロロ-フェノキシ)-フェニル]-1h-イミダゾール-4-イル}-フェノキシ)-プロピル]-ジエチル-アミンの代謝産物
|